Transition Therapeutics (TTHI) Reports Q3 Loss of CDN$0.11/Share

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/29/2026

1. NOW
2. GOOGL
3. MSFT
4. ENPH
5. BA
6. HOOD
7. SPY
8. STX
9. GOOG
10. NXPI

Go back to Transition Therapeutics (TTHI) Reports Q3 Loss of CDN$0.11/Share

Transition Therapeutics Announces Third Quarter Fiscal 2016 Financial Results

May 11, 2016 4:01 PM EDT

TORONTO, May 11, 2016 /PRNewswire/ - Transition Therapeutics Inc. ("Transition" or the "Company") (TSX: TTH; NASDAQ: TTHI), a biopharmaceutical development company advancing novel therapeutics for CNS, metabolic disease and androgen deficiency indications, today announced its financial results for the three and nine month periods ended March 31, 2016. Investors are invited to participate in a conference call today at 4:30pm EST to discuss these results.  Dial in information for the call is as follows: (800) 698-9012 (North America) and (303) 223-4374 (International).  A live webcast can be accessed via Transition's website... More